Necrotizing fasciitis caused by Shewanella putrefaciens in a uremic patient

Journal of Microbiology, Immunology and Infection

Volumn 39, Issue 6, 2006, Pages 516-518

  Tsai, Tsung Hung ^a,b,c   You, Hong Yi ^a  

^a Chia Yi Veterans Hospital   (Taiwan)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c NONE   (Taiwan)

Author keywords

Necrotizing fasciitis; Shewanella putrefaciens; Uremia

Indexed keywords

AMIKACIN; AZTREONAM; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; GENTAMICIN; MINOCYCLINE; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT;

AGED; ANAMNESIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; LABORATORY TEST; NECROTIZING FASCIITIS; PHYSICAL EXAMINATION; RADIODIAGNOSIS; SHEWANELLA PUTREFACIENS; UREMIA; DEBRIDEMENT; GRAM NEGATIVE INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; DEBRIDEMENT; FASCIITIS, NECROTIZING; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; SHEWANELLA PUTREFACIENS; TREATMENT OUTCOME; UREMIA;

EID: 33847760386     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. MacDonell MT, Colwell RR. Phylogeny of the Vibrionaceae, and recommendation for two new genera, Listonella and Shewanella. System Appl Microbiol 1985;6:171-82.
2. Derby HA, Hammer BW. Bacteriology of butter. IV. Bacteriological studies on surface tainted butter. Iowa Agric Exp Station Res Bull 1931;145:387-416.
3. Long HF, Hammer BW. Classification of organisms important in dairy products: III. Pseudomonas putrefaciens. Iowa Agric Exp Station Res Bull 1941;285:176-95.
4. Pivnick H. Pseudomonas rubescens, a new species from soluble oil emulsions. J Bacteriol 1955;70:1-6.
5. King EO. The identification of unusual pathogenic gram-negative bacteria. Atlanta: National Communicable Disease Center, 1964.
6. Pedersen MM, Marso E, Pickett MJ. Nonfermentative bacilli associated with man. 3. Pathogenicity and antibiotic susceptibility. Am J Clin Pathol 1970;54:178-92.
7. Baumann L, Baumann P, Mandel M, Allen RD. Taxonomy of aerobic marine eubacteria. J Bacteriol 1972;110:402-29.
8. von Graevenitz A. Ecology, clinical significance and antimicrobial susceptibility of infrequently encountered glucose-nonfermenting gram-negative rods. In: Gilardi GL, ed. Nonfermentative gram-negative rods; laboratory identification and clinical aspects. New York: Marcel Dekker; 1985:181-232.
9. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing. 12th informational supplement. NCCLS document M2-A7. Wayne, Pa: National Committee for Clinical Laboratory Standards; 2002.
10. Kim JH, Cooper RA, Welty-Wolf KE, Harrell LJ, Zwadyk P. Klotman ME. Pseudomonas putrefaciens bacteremia. Rev Infect Dis 1989;11:97-104.
11. Brink AJ, van Straten A, van Rensburg AJ. Shewanella (Pseudomonas) putrefaciens bacteremia. Clin Infect Dis 1995;20:1327-32.
12. Chen YS, Liu YC, Yen MY, Wang JH, Wang JH, Wann SR, et al. Skin and soft-tissue manifestations of Shewanella putrefaciens infection. Clin Infect Dis 1997;25:225-9.
13. Holt HM, Gahrn-Hansen B, Bruun B. Shewanella algae and Shewanella putrefaciens: clinical and microbiological characteristics. Clin Microbiol Infect 2005;11:347-52.
14. Chen SC, Lawrence RH, Packham DR, Sorrell TC. Cellulitis due to Pseudomonas putrefaciens: possible production of exotoxins. Rev Infect Dis 1991;13:642-3.
15. Dan M, Gutman R, Biro A. Peritonitis caused by Pseudomonas putrefaciens in patients undergoing continuous ambulatory peritoneal dialysis. Clin Infect Dis 1992;14:359-60.
16. Roger SD, Chen SC, Lawrence S, Sorrell TC. Pseudomonas putrefaciens bacteremia in a peritoneal dialysis patient. Nephrol Dial Transplant 1991;6:73.
17. Cohen G, Haag-Weber M, Horl WH. Immune dysfunction in uremia. Kidney Int Suppl 1997;52(Suppl 62):S79-82.
18. Edward L, Pesanti MD. Immunologic defects and vaccination in patients with chronic renal failure. Infect Dis Clin North Am 2001;15:813-32.